Skip to main content
. 2023 Nov 13;8(46):43490–43499. doi: 10.1021/acsomega.3c02921

Figure 1.

Figure 1

VINA docking: (a) Ranking of the FDA-approved drugs from the VINA docking calculations on the Spike glycoprotein of the first variant of SARS-CoV-2 virus. (b) Average opening of the RBD as a function of the interaction strength between the drug and the Spike protein. Four molecules showed the best ability to block the opening at the lowest strengths.